Coca-Cola FEMSA SAB (NYSE:KOF) shares traded down 3.1% on Friday . The stock traded as low as $76.01 and last traded at $76.62, with a volume of 68,541 shares traded. The stock had previously closed at $79.04.

Several research analysts have recently weighed in on the stock. Scotiabank reaffirmed a “sector perform” rating and issued a $139.00 price target on shares of Coca-Cola FEMSA SAB in a report on Thursday. Zacks Investment Research raised shares of Coca-Cola FEMSA SAB from a “sell” rating to a “hold” rating in a report on Friday, August 19th. Citigroup Inc. cut Coca-Cola FEMSA SAB from a “neutral” rating to a “sell” rating and reduced their target price for the company from $76.50 to $73.00 in a research note on Sunday, July 24th. Finally, JPMorgan Chase & Co. increased their target price on Coca-Cola FEMSA SAB from $82.00 to $89.00 and gave the company a “neutral” rating in a research note on Friday, June 3rd. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the stock. Coca-Cola FEMSA SAB presently has a consensus rating of “Hold” and a consensus target price of $88.38.

The company has a market cap of $15.90 billion and a PE ratio of 29.64. The stock’s 50-day moving average price is $79.12 and its 200 day moving average price is $79.52.

Coca-Cola FEMSA SAB (NYSE:KOF) last released its earnings results on Wednesday, July 27th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by $0.71. Equities analysts anticipate that Coca-Cola FEMSA SAB will post $3.74 EPS for the current fiscal year.

Coca-Cola FEMSA, SAB. de C.V. is a franchise bottler of Coca-Cola trademark beverages across the world. The Company and its subsidiaries are engaged in the production, distribution and marketing of certain Coca-Cola beverages. It is also engaged in acquiring, holding and transferring all types of bonds, shares and marketable securities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.